Clinical Trial Supply & Logistics For Pharmaceutical Market: By Service Type (Manufacturing, Packaging & Labeling, and Distribution & Storage), By Phase (Phase I, Phase II, Phase III, and Phase IV), By Therapeutic Area (Oncology, CNS, Cardiovascular, Infectious Diseases, and Others), and Geography

Clinical Trial Supply and Logistics for Pharmaceutical Market size was valued at approximately USD 15,629.7 million in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 7.1% from 2024 to 2030. This market encompasses services related to the manufacturing, packaging, labeling, storage, and distribution of clinical trial materials for pharmaceutical companies. The growth is primarily driven by the increasing number of clinical trials, rising complexity of trial designs, and the globalization of clinical research. According to ClinicalTrials.gov, as of May 2023, there were over 430,000 registered studies across 221 countries, indicating the vast scale of clinical trial activities worldwide.

The COVID-19 pandemic has further accelerated market growth by highlighting the importance of efficient supply chain management in clinical trials, with many companies adopting decentralized trial models. Additionally, the increasing focus on personalized medicine and rare diseases is contributing to the demand for specialized logistics services. The Tufts Center for the Study of Drug Development reported that rare disease trials grew by 88% between 2011 and 2020, requiring more complex supply chain solutions. However, challenges such as stringent regulatory requirements, temperature control issues, and the need for real-time tracking of clinical supplies may hinder market growth to some extent. The market is also influenced by technological advancements, with the integration of blockchain and IoT devices for enhanced traceability and temperature monitoring becoming increasingly prevalent.

Clinical Trial Supply and Logistics for Pharmaceutical Market Key Developments:

• In March 2023, Thermo Fisher Scientific expanded its clinical supply chain services with a new facility in Germany, enhancing its European distribution capabilities and introducing automated storage and retrieval systems.
• In August 2022, Marken, a critical part of UPS Healthcare, reached an agreement to purchase the medical courier business of Cedra Express, a New Zealand-based transportation and logistics provider serving the life science and pharmaceutical segment. This acquisition will enhance Marken’s presence and capabilities as a healthcare logistics provider in the region.